首页|骨形态发生蛋白9对肝细胞癌肿瘤干细胞干性、增殖和侵袭的影响及机制

骨形态发生蛋白9对肝细胞癌肿瘤干细胞干性、增殖和侵袭的影响及机制

扫码查看
目的 探讨骨形态发生蛋白9(BMP9)对肝细胞癌(HCC)肿瘤干细胞(CSCs)干性、增殖和侵袭的影响及机制。方法 取对数生长期的正常肝细胞、肝癌细胞、肝癌CSCs,采用RT-qPCR 法检测BMP9 mRNA表达,采用Western blotting法检测BMP9蛋白表达。采用慢病毒干扰载体转染肝细胞癌肿瘤干细胞(HepG2-CSCs)以敲低BMP9表达,并分成HepG2-CSCs 组、HepG2-CSCs-BMP9 敲低组。加入MAPK/ERK 信号激动剂(DIPQUO)后,将细胞分为三组:HepG2-CSCs组、HepG2-CSCs敲低组及HepG2-CSCs敲低+ DIPQUO组。采用RT-qPCR实验检测HepG2-CSCs 干性相关分子CD44、SOX2和OCT4表达,采用CCK-8实验检测细胞增殖能力,采用Transwell 实验检测细胞侵袭能力,采用蛋白印迹法检测MAPK/ERK 通路关键蛋白表达。结果 与正常肝细胞比,肝癌细胞和肝癌肿瘤干细胞(HepG2-CSCs)中BMP9表达上调(P<0。05)。HepG2 CSCs 细胞中BMP9 mRNA 和蛋白表达高于HepG2 细胞(P均<0。05)。BMP9 敲低后,HepG2-CSCs-BMP9 敲低组中HepG2-CSCs细胞中干细胞相关标志物CD44、SOX2、OCT4 mRNA表达较HepG2-CSCs 组降低(P均<0。05)。与HepG2-CSCs 组比较,HepG2-CSCs-BMP9 敲低组中HepG2-CSCs 在48、72和96 h的细胞增殖能力降低(P均<0。05),HepG2-CSCs 细胞迁移和侵袭能力降低(P均<0。05)。较HepG2-CSCs 组,HepG2-CSCs-BMP9 敲低组中HepG2-CSCs 中p-ERK1/2和 p-MEK1/2蛋白表达显著降低(P均<0。05)。HepG2-CSCs敲低+ DIPQUO组HepG2-CSCs 中干细胞相关标志物CD44、SOX2、OCT4 mRNA表达增加(P均<0。05),HepG2-CSCs增殖和侵袭能力增强(P均<0。05)。结论 BMP9 敲低可抑制 HepG2-CSCs干性维持并抑制细胞增殖、降低侵袭能力,机制可能与抑制 MAPK/ERK信号通路有关。
Effects and mechanism of BMP9 on stemness,proliferation and invasion of cancer stem cells in hepatocellular carcinoma
Objective To explore the effects and mechanism of bone morphogenetic protein 9(BMP9)on the stem-ness,proliferation and invasion of cancer stem cells(CSCs)in hepatocellular carcinoma(HCC).Methods Normal liv-er cells,liver carcinoma cells,and liver carcinoma tumor stem cells in the logarithmic growth phase were selected.RT-qP-CR was used to detect BMP9 mRNA expression.Western blotting was used to detect BMP9 protein expression.HepG2-CSCs were transfected with lentiviral interference vectors to knock down BMP9 expression,which were then divided into HepG2-CSCs group and HepG2-CSCs-BMP9 knockdown group.After adding MAPK/ERK signal agonists(DIPQUO),cells were divided into three groups,HepG2-CSCs group,HepG2-CSCs knockdown group,and HepG2-CSCs knockdown+ DIPQUO group.RT-qPCR was used to detect the expression levels of stemness-related molecules CD44,SOX2,and OCT4 in HepG2-CSCs.CCK-8 assay was used to detect cell proliferation ability.Transwell assay was used to detect cell in-vasion ability.Western blotting was used to detect the expression of key proteins in the MAPK/ERK pathway.Results Compared with normal liver cells,BMP9 expression was up-regulated in liver carcinoma cells and HepG2-CSCs(P<0.05).The BMP9 mRNA and protein expression levels in HepG2-CSCs were higher than those in HepG2 cells(both P<0.05).After BMP9 knockdown,the mRNA expression levels of stem cell-related markers CD44,SOX2,and OCT4 in HepG2 CSCs in the HepG2-CSCs-BMP9 knockdown group were lower than those in the HepG2-CSCs group(all P<0.05).Compared with the HepG2-CSCs group,BMP9 knockdown inhibited the cell proliferation ability of HepG2-CSCs in the HepG2-CSCs-BMP9 knockdown group at 48,72,and 96 h(all P<0.05),and inhibited the migration and invasion abili-ties of HepG2-CSCs cells(all P<0.05).Compared with the HepG2-CSCs group,after BMP9 knockdown,the expression levels of p-ERK1/2 and p-MEK1/2 proteins in the HepG2-CSCs-BMP9 knockdown group significantly decreased(all P<0.05).After adding DIPQUO,the expression levels of stem cell-related markers CD44,SOX2,and OCT4 mRNA increased in the HepG2-CSCs knockdown+DIPQUO group(all P<0.05),and the proliferation and invasion abilities of HepG2-CSCs were enhanced(all P<0.05).Conclusion Knockdown of BMP9 can inhibit the dry maintenance and pro-liferation and invasion functions of HepG2 CSCs,and the mechanism may be related to the inhibition of the MAPK/ERK pathway.

hepatocellular carcinomatumor stem cellsbone morphogenetic protein 9stem cell propertiescell proliferationcell invasion

卢金喜、余红梅、齐孝安、方超、魏新宝、李立鑫

展开 >

武汉市新洲区人民医院普通外科,武汉 430400

肝细胞癌 肿瘤干细胞 骨形态发生蛋白9 干细胞特性 细胞增殖 细胞侵袭

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(4)
  • 20